A-S Medication Solutions Announces Strategic Transition
01 July 2024 - 7:44PM
A-S Medication Solutions (ASM) today announced a strategic
transition of its relationship with Triple Aim Consulting, LLC
(“TAC”).
For a number of years, ASM has had a consulting agreement with
TAC for TAC to assist ASM in managing client accounts. That
consulting agreement ended on June 28, 2024.
“ASM is committed to increasing access to medications all across
the United States,” said ASM CEO Matt Hoff. “We are proud of
our tireless dedication to serving patients in all 50 states.”
Matt Hoff Chief Executive Officer (678)
488-7524
https://www.a-smeds.com/testimonials